Total Payments
$7,400
2024 Payments
$1,176
Companies
29
Transactions
438
Medicare Patients
2,875
Medicare Billing
$247,076
Payment Breakdown by Category
Food & Beverage$7,355 (99.4%)
Education$44.49 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,355 | 434 | 99.4% |
| Education | $44.49 | 4 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,499 | 99 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $999.90 | 47 | $0 (2024) |
| Lilly USA, LLC | $955.97 | 82 | $0 (2024) |
| Amgen Inc. | $623.83 | 34 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $541.36 | 18 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $439.36 | 26 | $0 (2021) |
| ABBVIE INC. | $374.64 | 22 | $0 (2024) |
| Amarin Pharma Inc. | $273.65 | 21 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $266.10 | 6 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $255.33 | 21 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,176 | 66 | Bayer Healthcare Pharmaceuticals Inc. ($348.67) |
| 2023 | $1,319 | 78 | Lilly USA, LLC ($367.25) |
| 2022 | $664.45 | 40 | Novo Nordisk Inc ($221.27) |
| 2021 | $680.18 | 45 | Novo Nordisk Inc ($187.55) |
| 2020 | $823.60 | 52 | AstraZeneca Pharmaceuticals LP ($267.22) |
| 2019 | $667.41 | 36 | AstraZeneca Pharmaceuticals LP ($209.49) |
| 2018 | $642.09 | 32 | AstraZeneca Pharmaceuticals LP ($196.16) |
| 2017 | $1,428 | 89 | AstraZeneca Pharmaceuticals LP ($285.22) |
All Payment Transactions
438 individual payment records from CMS Open Payments — Page 3 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: NEUROSCIENCE | ||||||
| 03/15/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/08/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: Diabetes | ||||||
| 03/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Inflammation | ||||||
| 03/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: NEUROSCIENCE | ||||||
| 02/29/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $8.21 | General |
| Category: Diabetes | ||||||
| 02/20/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: Diabetes | ||||||
| 02/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/12/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Diabetes | ||||||
| 02/01/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $9.74 | General |
| Category: Diabetes | ||||||
| 02/01/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $2.45 | General |
| Category: Diabetes | ||||||
| 01/27/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $20.90 | General |
| 01/22/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $6.10 | General |
| Category: Diabetes | ||||||
| 01/12/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Diabetes | ||||||
| 01/06/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Diabetes | ||||||
| 01/05/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $3.35 | General |
| Category: Diabetes | ||||||
| 12/28/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $7.27 | General |
| Category: Diabetes | ||||||
| 12/22/2023 | Alvogen Inc | TERIPARATIDE (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: OSTEOPOROSIS | ||||||
| 12/18/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Gastroenterology | ||||||
| 12/12/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: Inflammation | ||||||
| 12/08/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/01/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Diabetes | ||||||
| 11/11/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Diabetes | ||||||
| 11/08/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $6.85 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 333 | 578 | $107,374 | $35,906 |
| 2022 | 13 | 605 | 1,046 | $91,750 | $60,429 |
| 2021 | 20 | 770 | 1,332 | $106,970 | $68,599 |
| 2020 | 20 | 1,167 | 2,390 | $151,095 | $82,141 |
Total Patients
2,875
Total Services
5,346
Medicare Billing
$247,076
Procedure Codes
63
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 109 | 265 | $69,524 | $22,953 | 33.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 74 | 136 | $25,045 | $8,436 | 33.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 35 | 37 | $4,765 | $1,712 | 35.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 17 | 17 | $3,009 | $1,156 | 38.4% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 13 | 13 | $975.00 | $433.51 | 44.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 13 | 13 | $650.00 | $383.63 | 59.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 18 | 34 | $1,052 | $333.87 | 31.7% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 17 | 17 | $680.00 | $299.03 | 44.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 14 | 16 | $160.00 | $134.40 | 84.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 23 | 30 | $1,514 | $66.00 | 4.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 120 | 330 | $42,900 | $28,855 | 67.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 77 | 139 | $13,205 | $8,871 | 67.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 60 | 60 | $12,000 | $7,563 | 63.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 40 | 132 | $7,260 | $5,692 | 78.4% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 50 | 50 | $5,000 | $4,050 | 81.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 11 | 11 | $2,750 | $1,776 | 64.6% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 74 | 74 | $1,850 | $1,334 | 72.1% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2022 | 11 | 32 | $2,400 | $836.05 | 34.8% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 31 | 31 | $775.00 | $549.00 | 70.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 24 | 35 | $1,050 | $354.31 | 33.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 60 | 88 | $880.00 | $260.37 | 29.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 15 | 18 | $990.00 | $186.56 | 18.8% |
| 81003 | Automated urinalysis test | Office | 2022 | 32 | 46 | $690.00 | $102.23 | 14.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 122 | 339 | $44,070 | $30,657 | 69.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 95 | 226 | $21,455 | $14,037 | 65.4% |
About Dr. Melecia Fuentes, M.D
Dr. Melecia Fuentes, M.D is a Family Medicine healthcare provider based in Weslaco, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083713952.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Melecia Fuentes, M.D has received a total of $7,400 in payments from pharmaceutical and medical device companies, with $1,176 received in 2024. These payments were reported across 438 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($7,355).
As a Medicare-enrolled provider, Fuentes has provided services to 2,875 Medicare beneficiaries, totaling 5,346 services with total Medicare billing of $247,076. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Weslaco, TX
- Active Since 09/21/2006
- Last Updated 07/03/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1083713952
Products in Payments
- FARXIGA (Drug) $890.27
- Ozempic (Drug) $780.89
- MOUNJARO (Drug) $559.71
- Kerendia (Drug) $541.36
- JARDIANCE (Drug) $356.80
- Rybelsus (Drug) $297.10
- Vascepa (Drug) $273.65
- Livalo (Drug) $255.33
- Victoza (Drug) $240.66
- TOUJEO (Drug) $198.59
- TRULICITY (Drug) $174.03
- Prolia (Biological) $168.43
- XARELTO (Drug) $165.42
- Otezla (Drug) $148.96
- Aimovig (Biological) $148.50
- SOLIQUA (Drug) $135.84
- VRAYLAR (Drug) $128.66
- Synthroid (Drug) $125.80
- BYDUREON (Drug) $109.63
- INVOKANA (Drug) $100.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Weslaco
Dr. Alejandro Fuentes, M.d, M.D
Family Medicine — Payments: $5,116
Family Medicine $5,116
Dr. Donna Mery, M.d, M.D
Family Medicine — Payments: $4,323
Family Medicine $4,323
Dr. Roger Heredia, M.d, M.D
Family Medicine — Payments: $3,405
Family Medicine $3,405
Larissa Riojas, Do, DO
Family Medicine — Payments: $3,282
Family Medicine $3,282
Martha Cano, Md, MD
Family Medicine — Payments: $2,563
Family Medicine $2,563
Pamela Ramirez Stroman, M.d, M.D
Family Medicine — Payments: $2,176
Family Medicine $2,176